GL1X · GenesisL1 explorer

MolNFT v1 · #169385 · protein

SARS cov-2 plpro in complex with ubiquitin propargylamide

6XAA · Non-structural protein 3: “SARS cov-2 plpro in complex with ubiquitin propargylamide”. X-ray diffraction, 2 ligands (AYE, ZN), 3 pockets (best druggability 0.67). MolNFT v1 #169385 on GenesisL1: 3D structure, binding sites and…

PDB
6XAA
Type
protein
Length
384 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-structural protein 3; Ubiquitin-propargylamide
EC
3.4.19.121, 3.4.22.-
UniProt
P0DTD1, J3QS39
Ligands
AYE, ZN
Pockets
3 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 25% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein30927% helix, 37% strandP0DTD1
BUbiquitin-propargylamideprotein7516% helix, 33% strandJ3QS39

Ligands and binding sites

  • AYE · prop-2-en-1-amine · ligand · chains A, B
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13740.670.8042empty
21130.480.8026empty
3680.430.8118empty

Interfaces

1 interface between chains.

  • A–B · 1009 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 6XAA · SARS CoV-2 PLpro in complex with ubiquitin propargylamide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.